(Q24246302)

https://api.crossref.org/works/10.1002%2F14651858.CD003594.PUB3

A randomized open-label comparative study of conventional therapy versus mizoribine onlay therapy in patients with steroid-resistant nephrotic syndrome (postmarketing survey).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003594.PUB3

Identifying relevant studies for systematic reviews

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003594.PUB3

Bias in meta-analysis detected by a simple, graphical test

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003594.PUB3

What is meant by intention to treat analysis? Survey of published randomised controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003594.PUB3

Treatment of childhood steroid-resistant idiopathic nephrosis with a combination of cyclosporine and prednisone. French Society of Pediatric Nephrology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003594.PUB3

Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003594.PUB3

7 January 2021

Interventions for idiopathic steroid-resistant nephrotic syndrome in children

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003594.PUB3

7 January 2021

Comparison of cyclosporin and chlorambucil in the treatment of steroid-dependent idiopathic nephrotic syndrome: a multicentre randomized controlled trial. The French Society of Paediatric Nephrology

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003594.PUB3

7 January 2021

Intravenous pulse cyclophosphamide--a new regime for steroid-resistant minimal change nephrotic syndrome.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003594.PUB3

7 January 2021

A meta-analysis of cytotoxic treatment for frequently relapsing nephrotic syndrome in children

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003594.PUB3

7 January 2021

Interventions for steroid-resistant nephrotic syndrome: a systematic review

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003594.PUB3

7 January 2021

Enalapril dosage in steroid-resistant nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003594.PUB3

7 January 2021

Cyclophosphamide does not benefit patients with focal segmental glomerulosclerosis. A report of the International Study of Kidney Disease in Children.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003594.PUB3

7 January 2021

Steroid-resistant nephrotic focal segmental glomerulosclerosis: a treatable disease

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003594.PUB3

7 January 2021

Treatment of focal glomerulosclerosis with pulse steroids and oral cyclophosphamide

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003594.PUB3

7 January 2021

The primary nephrotic syndrome in children. Identification of patients with minimal change nephrotic syndrome from initial response to prednisone. A report of the International Study of Kidney Disease in Children

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003594.PUB3

7 January 2021

164 children with nephrosis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003594.PUB3

7 January 2021

Controlled trial of azathioprine in children with nephrotic syndrome. A report for the international study of kidney disease in children

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003594.PUB3

7 January 2021

Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003594.PUB3

7 January 2021

Primary nephrotic syndrome in children: clinical significance of histopathologic variants of minimal change and of diffuse mesangial hypercellularity. A Report of the International Study of Kidney Disease in Children

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003594.PUB3

7 January 2021

A randomized trial of cyclosporine in steroid-resistant idiopathic nephrotic syndrome.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003594.PUB3

7 January 2021

Long-term outcome in children and adults with classic focal segmental glomerulosclerosis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003594.PUB3

7 January 2021

A controlled trial of cyclophosphamide and azathioprine in Nigerian children with the nephrotic syndrome and poorly selective proteinuria

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003594.PUB3

7 January 2021

Long-term outcome of primary nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003594.PUB3

7 January 2021

Measuring inconsistency in meta-analyses

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003594.PUB3

7 January 2021